Literature DB >> 12810526

Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease.

Tamas L Horvath1, Sabrina Diano, Csaba Leranth, Luis Miguel Garcia-Segura, Michael A Cowley, Marya Shanabrough, John D Elsworth, Peter Sotonyi, Robert H Roth, Edwin H Dietrich, Russel T Matthews, Colin J Barnstable, D Eugene Redmond.   

Abstract

Parkinson's disease is characterized by dopamine cell loss of the substantia nigra. Parkinson's disease and the neurotoxin 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine may destroy dopamine neurons through oxidative stress. Coenzyme Q is a cofactor of mitochondrial uncoupling proteins that enhances state-4 respiration and eliminate superoxides. Here we report that short-term oral administration of coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss after 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine administration in monkeys.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810526     DOI: 10.1210/en.2003-0163

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

Review 1.  Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Authors:  M Flint Beal
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

2.  Susceptibility to a parkinsonian toxin varies during primate development.

Authors:  B A Morrow; R H Roth; D E Redmond; S Diano; J D Elsworth
Journal:  Exp Neurol       Date:  2012-02-14       Impact factor: 5.330

3.  Compensatory proteome adjustments imply tissue-specific structural and metabolic reorganization following episodic hypoxia or anoxia in the epaulette shark (Hemiscyllium ocellatum).

Authors:  W Wesley Dowd; Gillian M C Renshaw; Joseph J Cech; Dietmar Kültz
Journal:  Physiol Genomics       Date:  2010-04-06       Impact factor: 3.107

4.  Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.

Authors:  Magali Dumont; Khatuna Kipiani; Fangmin Yu; Elizabeth Wille; Maya Katz; Noel Y Calingasan; Gunnar K Gouras; Michael T Lin; M Flint Beal
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 5.  Parkinson's disease: oxidative stress and therapeutic approaches.

Authors:  Sankar Surendran; Srinivasagam Rajasankar
Journal:  Neurol Sci       Date:  2010-03-10       Impact factor: 3.307

Review 6.  The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.

Authors:  Zhen-Guo Zhu; Miao-Xuan Sun; Wan-Li Zhang; Wen-Wen Wang; Yi-Mei Jin; Cheng-Long Xie
Journal:  Neurol Sci       Date:  2016-11-09       Impact factor: 3.307

7.  Functional characterization of a Drosophila mitochondrial uncoupling protein.

Authors:  Yih-Woei C Fridell; Adolfo Sánchez-Blanco; Brian A Silvia; Stephen L Helfand
Journal:  J Bioenerg Biomembr       Date:  2004-06       Impact factor: 2.945

8.  Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease.

Authors:  Teri L Wadsworth; James A Bishop; Anuradha S Pappu; Randall L Woltjer; Joseph F Quinn
Journal:  J Alzheimers Dis       Date:  2008-06       Impact factor: 4.472

Review 9.  Perspectives on mitochondrial uncoupling proteins-mediated neuroprotection.

Authors:  Susana Cardoso; Sónia Correia; Cristina Carvalho; Emanuel Candeias; Ana I Plácido; Ana I Duarte; Raquel M Seiça; Paula I Moreira
Journal:  J Bioenerg Biomembr       Date:  2014-09-14       Impact factor: 2.945

Review 10.  Mitochondrial medicine for neurodegenerative diseases.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Int J Biochem Cell Biol       Date:  2010-01-11       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.